Fowlpox virus rFPV-AIH5/IL2, construction method and use thereof
A fowlpox virus and IL2 technology, applied in the direction of virus/bacteriophage, antiviral agents, and microbial-based methods, can solve the problem of low immune efficacy and achieve the effect of improving immune protection and preventing H5 subtype avian influenza
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment Construction
[0056] The following relates to biological material recombinant fowlpox virus (Fowlpox virus) rFPV-AIH5 / IL2, which was deposited in the General Microbiology Center of China Committee for the Collection of Microorganisms on December 25, 2008, and the preservation number is CGMCC: 2831.
[0057] T-HA: Jia Lijun, Peng Daxin, Zhang Yanmei, et al. Construction of H5 subtype avian influenza recombinant fowlpox virus live vector vaccine and its genetic stability and immune efficacy. Acta Microbiology, 2003 43, (6): 722-727.
[0058] PT-IL2: Shao Weixing, Peng Daxin, Lu Jianhong, et al. Construction of recombinant fowlpox virus expressing chicken interleukin 2 and detection of biological activity of its expression product in vitro. Acta Biological Engineering, 2004, 20(1): 136-139.
[0059] pGEM-T easy vector: purchased from Promega.
[0060] PUC18PELNA: Chen Sujuan. Construction of single or double expression recombinant vaccines against H5 and H9 subtype avian influenza with differe...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com